Related references
Note: Only part of the references are listed.Mitochondria-targeted polymer-celastrol conjugate with enhanced anticancer efficacy
Yu Geng et al.
JOURNAL OF CONTROLLED RELEASE (2022)
Polarization of tumor-associated macrophages by TLR7/8 conjugated radiosensitive peptide hydrogel for overcoming tumor radioresistance
Yumin Zhang et al.
BIOACTIVE MATERIALS (2022)
Targeted Intervention of NF2-YAP Signaling Axis in CD24-Overexpressing Cells Contributes to Encouraging Therapeutic Effects in TNBC
Lingmi Hou et al.
ACS NANO (2022)
Multifunctional Size-Expandable Nanomedicines Enhance Tumor Accumulation and Penetration for Synergistic Chemo-Photothermal Therapy
Yuai Li et al.
ACS APPLIED MATERIALS & INTERFACES (2021)
Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment
Wenxi Zhou et al.
BIOMATERIALS (2021)
Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy
Nasha Qiu et al.
BIOMATERIALS (2021)
A siRNA-Assisted Assembly Strategy to Simultaneously Suppress Self and Upregulate Eat-Me Signals for Nanoenabled Chemo-Immunotherapy
Yuxi Zhang et al.
ACS NANO (2021)
Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction
Ming Zhao et al.
JOURNAL OF CONTROLLED RELEASE (2021)
HIF1α epigenetically repressed macrophages via CRISPR/Cas9-EZH2 system for enhanced cancer immunotherapy
Yan Dong et al.
BIOACTIVE MATERIALS (2021)
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold (vol 178, 585.e1, 2019)
David W. Vredevoogd et al.
CELL (2020)
Functional Gadofullerene Nanoparticles Trigger Robust Cancer Immunotherapy Based on Rebuilding an Immunosuppressive Tumor Microenvironment
Lei Li et al.
NANO LETTERS (2020)
Molecular Mechanism of Tumor Cell Immune Escape Mediated by CD24/Siglec-10
Shan-Shan Yin et al.
FRONTIERS IN IMMUNOLOGY (2020)
Activating Macrophage-Mediated Cancer Immunotherapy by Genetically Edited Nanoparticles
Lang Rao et al.
ADVANCED MATERIALS (2020)
Intratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity
Meiling Yu et al.
CANCER LETTERS (2019)
Barcoding reveals complex clonal behavior in patient-derived xenografts of metastatic triple negative breast cancer
D. Merino et al.
NATURE COMMUNICATIONS (2019)
Tumors and Their Microenvironment Dual-Targeting Chemotherapy with Local Immune Adjuvant Therapy for Effective Antitumor Immunity against Breast Cancer
Caifeng Deng et al.
ADVANCED SCIENCE (2019)
CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy
Amira A. Barkal et al.
NATURE (2019)
Self-Amplified Drug Delivery with Light-Inducible Nanocargoes to Enhance Cancer Immunotherapy
Bing Feng et al.
ADVANCED MATERIALS (2019)
Genetic programming of macrophages to perform anti-tumor functions using targeted mRNA nanocarriers
F. Zhang et al.
NATURE COMMUNICATIONS (2019)
Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy
Qian Chen et al.
ADVANCED MATERIALS (2019)
Tumor Microenvironment-Activatable Prodrug Vesicles for Nanoenabled Cancer Chemoimmunotherapy Combining Immunogenic Cell Death Induction and CD47 Blockade
Fangyuan Zhou et al.
ADVANCED MATERIALS (2019)
Enhanced Immunotherapy Based on Photodynamic Therapy for Both Primary and Lung Metastasis Tumor Eradication
Wen Song et al.
ACS NANO (2018)
Nanocarrier-Mediated Chemo-Immunotherapy Arrested Cancer Progression and Induced Tumor Dormancy in Desmoplastic Melanoma
Qi Liu et al.
ACS NANO (2018)
Quantifying the Ligand-Coated Nanoparticle Delivery to Cancer Cells in Solid Tumors
Qin Dai et al.
ACS NANO (2018)
Enzyme-triggered size shrink and laser-enhanced NO release nanoparticles for deep tumor penetration and combination therapy
Chuan Hu et al.
BIOMATERIALS (2018)
Size shrinkable drug delivery nanosystems and priming the tumor microenvironment for deep intratumoral penetration of nanoparticles
Yimin Niu et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Chemotherapy induces enrichment of CD47+/CD73+/PDL1+ immune evasive triple-negative breast cancer cells
Debangshu Samanta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Cancer immunotherapy using checkpoint blockade
Antoni Ribas et al.
SCIENCE (2018)
The homeobox protein VentX reverts immune suppression in the tumor microenvironment
Yi Le et al.
NATURE COMMUNICATIONS (2018)
Binary Cooperative Prodrug Nanoparticles Improve Immunotherapy by Synergistically Modulating Immune Tumor Microenvironment
Bing Feng et al.
ADVANCED MATERIALS (2018)
Near-Infrared Laser-Driven in Situ Self-Assembly as a General Strategy for Deep Tumor Therapy
Fu-Hua Liu et al.
NANO LETTERS (2018)
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies (vol 33, pg 581, 2018)
Roberta Zappasodi et al.
CANCER CELL (2018)
A circulating cell population showing both M1 and M2 monocyte/macrophage surface markers characterizes systemic sclerosis patients with lung involvement
Amelia Chiara Trombetta et al.
RESPIRATORY RESEARCH (2018)
Identification of a novel single chain fragment variable antibody targeting CD24-expressing cancer cells
Shirin Eyvazi et al.
IMMUNOLOGY LETTERS (2017)
Mitochondrial dynamics controls anti-tumour innate immunity by regulating CHIP-IRF1 axis stability
Zhengjun Gao et al.
NATURE COMMUNICATIONS (2017)
Current Multistage Drug Delivery Systems Based on the Tumor Microenvironment
Binlong Chen et al.
THERANOSTICS (2017)
Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages
Yuan Qian et al.
ACS NANO (2017)
Immunotherapy for triple-negative breast cancer: Existing challenges and exciting prospects
Hongyan Jia et al.
DRUG RESISTANCE UPDATES (2017)
Prospects for combining targeted and conventional cancer therapy with immunotherapy
Philip Gotwals et al.
NATURE REVIEWS CANCER (2017)
Immune suppressive mechanisms in the tumor microenvironment
David H. Munn et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Expression of Tumor-Related Macrophages and Cytokines After Surgery of Triple-Negative Breast Cancer Patients and its Implications
Jianguo Wang et al.
MEDICAL SCIENCE MONITOR (2016)
Macrophages and Therapeutic Resistance in Cancer
Brian Ruffell et al.
CANCER CELL (2015)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
IDO inhibitors move center stage in immuno-oncology
Cormac Sheridan
NATURE BIOTECHNOLOGY (2015)
CD47 blockade triggers T cell-mediated destruction of immunogenic tumors
Xiaojuan Liu et al.
NATURE MEDICINE (2015)
The future of immune checkpoint therapy
Padmanee Sharma et al.
SCIENCE (2015)
Human breast cancer cells educate macrophages toward the M2 activation status
Sofia Sousa et al.
BREAST CANCER RESEARCH (2015)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Cross-presentation by dendritic cells
Olivier P. Joffre et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Triple-negative breast cancer: disease entity or title of convenience?
Lisa Carey et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Share Paper
